Faro Secures $37 Million in Latest Series B Funding Round

Faro secured $37 million in its latest Series B, adding another data point to the FinTech funding market.

Faro Raises $37 million in Funding

Faro raises $37M Series B to trim clinical trial timelines with AI. Faro is betting AI can compress trial timelines, potentially in half.

Investors Behind the Funding

The round was backed by Merck Global Health Innovation Fund. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Faro operates in FinTech. Faro's financing adds to recent private-market activity.

Strategic Use of Funds

Trim clinical trial timelines with AI.

Looking Ahead

By saving time and improving quality, agentic AI has the potential to transform the way the biopharmaceutical industry conducts clinical development,

Source reference: original announcement/article.